Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-072622
Filing Date
2025-05-15
Accepted
2025-05-15 16:10:25
Documents
61
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q apvo-20250331.htm   iXBRL 10-Q 1517532
2 EX-31.1 apvo-ex31_1.htm EX-31.1 17029
3 EX-31.2 apvo-ex31_2.htm EX-31.2 17264
4 EX-32.1 apvo-ex32_1.htm EX-32.1 10426
5 EX-32.2 apvo-ex32_2.htm EX-32.2 11072
  Complete submission text file 0000950170-25-072622.txt   6422511

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apvo-20250331.xsd EX-101.SCH 1190788
64 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20250331_htm.xml XML 774511
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37746 | Film No.: 25953041
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)